I am a strong advocate for Cannapil but the main issue of MXC is its 1.2 billion shares dilution. Furthermore, if we also take their options issued into account, it will be well above 1.2 billions! It is hard to justify its market cap with its 81k sales revenue last quarter. Also, their expected profit for cannipil is only 1 million, in this sense, the current SP is well overvalued.
Correct me if I am wrong.
DYOR AIMO
- Forums
- ASX - By Stock
- RGT
- Finfeed
Finfeed, page-5
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.00M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 313 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 0.310 |
2 | 3844 | 0.290 |
2 | 20000 | 0.270 |
1 | 4000 | 0.250 |
1 | 17426 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 313 | 1 |
0.305 | 45198 | 3 |
0.315 | 2825 | 2 |
0.340 | 2115 | 2 |
0.370 | 1056 | 1 |
Last trade - 16.16pm 12/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
Day chart unavailable